Table 3.
Vaccine effectiveness (VE) for double doses of the BBV-152 and AZD1222 vaccines.
| Vaccination status | COVISHIELD (AZD1222) | COVAXIN (BBV-152) | ||||||
|---|---|---|---|---|---|---|---|---|
| Cases | Controls | VE (95% CI) | Adj. VE * (95% CI) | Cases | Controls | VE (95% CI) | Adj. VE * (95% CI) | |
| Unvaccinated | 713 (57.3) | 532 (42.7) | Ref. | Ref. | 713 (57.3) | 532 (42.7) | Ref. | Ref. |
| Double dose | 28 (28.6) | 70 (71.4) | 70.2% (53.1%−81.0%) | 79.0% (65.4%−87.2%) | 19 (32.2) | 40 (67.8) | 65.0% (38.9%−80.0%) | 74.0% (50.5%−86.0%) |
Adjusted for age, sex, and number of comorbidities.